Search Login Register

Immediate Hypersensitivity Summary

Description: Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.

Also Known As: Hypersensitivity, Immediate; Atopic Hypersensitivities; Hypersensitivities, Atopic; Hypersensitivities, IgE-Mediated; Hypersensitivities, Immediate Show All >>

Networked: 1523 relevant articles (23 outcomes, 103 trials/studies) for this Disease

Key Drugs and Agents for Immediate Hypersensitivity

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Immunoglobulin E (IgE) : 6 outcomes 28 studies in 481 results : IBA
  2. Antigens : 3 outcomes 7 studies in 171 results : IBA
  3. Allergens : 2 outcomes 11 studies in 123 results : IBA
  4. Immunoglobulin G (IgG) : 1 outcome 3 studies in 46 results : IBA
  5. Penicillins (Penicillin) : 1 outcome 2 studies in 42 results : FDA 1
  6. Interleukin-4 (Interleukin 4) : 1 outcome 2 studies in 17 results : IBA
  7. Carrageenan : 1 outcome 2 studies in 4 results : IBA
  8. Histamine (Histamine Dihydrochloride) : 1 outcome 1 study in 67 results : FDA 1
  9. Dust (House Dust) : 1 outcome 1 study in 11 results : FDA 1
  10. Cromolyn Sodium (Cromoglicic Acid) : 1 outcome 1 study in 8 results : FDA 26 Generic
Show All >>

Diseases Related to Immediate Hypersensitivity

  1. Hypersensitivity (Allergy)
  2. Infection
  3. Anaphylaxis (Anaphylactic Shock)
  4. Inflammation
  5. Rhinitis
Show All >>

Key Therapies for Immediate Hypersensitivity

Efficacy Chart >>
  1. Autonomic Nerve Block : 1 outcome in 1 result
  2. Intranasal Administration : 1 outcome in 1 result
  3. Injections : 1 study in 7 results
  4. Premedication : 1 study in 6 results
  5. Drug Therapy (Chemotherapy) : 1 study in 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.